New study sheds light on why GLP-1s could mitigate alcohol abuse


This recording was made using enhanced software.

Summary

GLP-1s and intoxication

A new study published Wednesday in the journal Scientific Reports found that GLP-1s slow the absorption of alcohol into the bloodstream, thus minimizing its effects on the brain.

Study methods

The researchers recruited 24 people with obesity, half of whom were taking GLP-1s. As each person consumed alcoholic drinks, those who were also taking GLP-1s reported feeling less intoxicated.

Mitigating abuse

According to the study’s researchers, faster-acting drugs have a higher potential for abuse. So if GLP-1s can slow alcohol’s effects on the body, they could also mitigate the possibility of abuse.


Full story

Back in May, a study was published suggesting that popular weight-loss drugs such as Ozempic and Wegovy could curb alcohol cravings by as much as 70%. At the time, researchers weren’t entirely sure why the GLP-1s had such a profound effect on alcohol receptors, but that may have all changed. 

How do GLP-1s work?

A new study published Wednesday in the journal Scientific Reports found that GLP-1s slow the absorption of alcohol into the bloodstream, thus minimizing its effects on the brain. It’s not entirely different from what GLP-1s do with food, which is to resemble the GLP-1 hormone and effectively slow digestion. 

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

As a result, researchers found, a person doesn’t feel the effects of alcohol as intensely when taken with GLP-1s. The study could open a host of possibilities for both casual drinkers and those who suffer from alcohol dependency. 

Study methods

For the study, a team of researchers at Virginia Tech, led by Dr. Alex DiFeliceantonio, recruited 24 participants with obesity, half of whom take GLP-1s to manage their weight. 

Over the course of an hour, each of those individuals was served three alcoholic drinks, which they were required to finish within 10 minutes. Following that, they were given a breathalyzer and asked to quantify their intoxication on a scale of 1 to 10.

What the researchers found was that those who were taking GLP-1s also reported lower levels of intoxication. Incidentally, the slower the alcohol takes over the bloodstream and brain, the easier it is for someone to manage their intake.    

Helping people drink less

“People who drink know there’s a difference between nursing a glass of wine and downing a shot of whiskey,” DiFeliceantonio said, adding that while both beverages contain the same amount of alcohol, taking a shot impacts the alcohol level of a person’s bloodstream much quicker. 

“Why would this matter? Faster-acting drugs have a higher abuse potential,” DiFeliceantonio said. “They have a different impact on the brain. So if GLP-1s slow alcohol entering the bloodstream, they could reduce the effects of alcohol and help people drink less.”

Diane Duenez (Managing Weekend Editor) contributed to this report.
Tags: , , ,

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Why this story matters

A new study suggests that GLP-1 weight loss drugs may reduce alcohol absorption and intoxication, which could impact the understanding and treatment of alcohol use and dependency.

GLP-1 effects

GLP-1 drugs, commonly used for weight loss, may also slow alcohol absorption and lessen intoxication, potentially affecting both social and medical approaches to drinking.

Alcohol use disorder treatment

According to Virginia Tech researchers, these drugs may open new possibilities for helping people manage alcohol intake or dependency, offering another potential therapeutic benefit.

Scientific research

Findings from controlled clinical studies, such as this one involving participants at Virginia Tech, add to the scientific understanding of how GLP-1s interact with substances beyond food.

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Daily Newsletter

Start your day with fact-based news

Start your day with fact-based news

Learn more about our emails. Unsubscribe anytime.

By entering your email, you agree to the Terms and Conditions and acknowledge the Privacy Policy.